Clinical Trial Update: The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessed whether systolic blood pressure reduction with the combination of valsartan and amlodipine improves diastolic function in patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diastolic Dysfunction
• Hypertension

Drugs mentioned

• Amlodipine (amlodipine)
• VALSARTAN (Valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension, Diastolic Dysfunction | Phase 4 | Status: COMPLETED | Results posted: 2011-03-10